Bayer HealthCare Pharmaceuticals (BAYA.F) to Present New Data Across Oncology Portfolio at American Society of Clinical Oncology 2013
5/16/2013 7:01:39 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F) Initiates Phase III Trial of Stivarga® (regorafenib) Tablets in Patients with Advanced Liver Cancer
5/15/2013 9:10:49 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F) Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients With Gram-Negative Pneumonia
4/16/2013 9:35:48 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F) Release: Fight Colorectal Cancer Battles Cancer at One of the Busiest Attractions in the World
3/1/2013 9:58:08 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F) Opposes the Formation of a Mirena MDL
2/28/2013 8:25:59 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F), Onyx Pharmaceuticals, Inc. (ONXX) Drug Meets Goal in Thyroid Cancer Trial
1/3/2013 6:54:20 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F) Submits New Drug Application for Radium Ra 223 Dichloride for the Treatment of Castration-Resistant Prostate Cancer (CRPC) with Bone Metastases
12/14/2012 9:53:01 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F) Announces Recruitment Achievement for Investigational Hemophilia Treatment
11/28/2012 8:32:50 AM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F)s Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
11/9/2012 2:02:39 PM
More...
|
Bayer HealthCare Pharmaceuticals (BAYA.F)'s Stivarga® (Regorafenib) Tablets New Drug Application Granted Priority Review by U.S. FDA for the Treatment of Patients with Gastrointestinal Stromal Tumors
10/29/2012 10:38:21 AM
More...
|
|